Literature DB >> 196714

[3H]dihydroergocryptine binding in rat brain.

J N Davis, W J Strittmatter, E Hoyler, R J Leefkowitz.   

Abstract

[3H]dihydroergocryptine (DHE) appears to bind to alpha-adrenergic receptor sites in rabbit uterine membranes. We have characterized the binding of [3H]DHE to membranes prepared from rat cerebral cortex. alpha-Adrenergic agents were less potent and dopamine and serotonin, more potent, in displacing brain DHE binding than in uterus. Furthermore brain DHE binding sites demonstrated less stereospecificity for catecholamines than sites in uterus. Dopamine displaced DHE binding with about the same potency in cerebellar and cerebral cortical membranes, but was 10 times as potent in displacing DHE binding in the striatum. The binding of [3H]DHE in brain is complex and differs significantly from the rabbit uterus. There are two possible explanations for this discrepancy. [3H]DHE may bind a single site in brain with properties differing from known peripheral adrenergic receptors or DHE may bind to multiple sites in brain, sites which may or may not represent other neurotransmitter receptors.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 196714     DOI: 10.1016/0006-8993(77)90425-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Characterization of the human platelet alpha-adrenergic receptor. Correlation of [3H]dihydroergocryptine binding with aggregation and adenylate cyclase inhibition.

Authors:  R W Alexander; B Cooper; R I Handin
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

2.  Selective labeling of alpha-adrenergic receptors in caudate nucleus by [3H] dihydroergocryptine in the presence of spiperone-blocked dopamine receptors.

Authors:  M Titeler; P Seeman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

3.  Prolactin lowering effect of dihydroergokryptine in rat and in man.

Authors:  M Poli; D Cocchi; F Mailland; A M Masu; G Landi; A Craveri; E E Müller
Journal:  J Endocrinol Invest       Date:  1986-02       Impact factor: 4.256

4.  Classification of drugs according to receptor binding profiles.

Authors:  A Closse; W Frick; A Dravid; G Bolliger; D Hauser; A Sauter; H J Tobler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

5.  Effect of bromocriptine administration on gastric acid and gastrin secretion in man.

Authors:  R Caldara; C Ferrari; M Romussi; A Paracchi
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

6.  Demonstration of alpha-adrenoceptors in the rabbit heart by [3H]-dihydroergocryptine binding.

Authors:  H J Schümann; O E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-09       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.